logo-loader
viewCellmid Limited

Cellmid CEO and MD Maria Halasz acquires shares in on-market transactions

The company is developing solutions to a range of conditions associated with ageing and inflammatory and autoimmune conditions.

Cellmid Limited - Cellmid CEO and MD Maria Halasz acquires further shares in on-market transaction
Cellmid has operations in Australia, Japan, the USA, Europe and Asia

Cellmid Ltd (ASX:CDY) chief executive officer and MD Maria Halasz has demonstrated her confidence in the company's strategy by acquiring shares in on-market transactions.

Halasz made the purchases totalling more than 152,000 in an indirect interest on June 18 and 22.

She acquired 100,000 shares at 11 cents per share and a further 52,789 shares at 12 cents per share, bringing the total number of shares held in that interest to 2.58 million with another 420,000 held in a direct interest.

Participation in placement

The on-market purchases follow her participation in the company’s placement earlier this year after receiving shareholder approval.

She acquired 227,273 shares at 22 cents per share with a total value of $50,000 in the indirect interest.

Also on June 18, non-executive director Dennis Eck acquired more than 4.318 million shares with a value of $950,000 in the placement.

Quick facts: Cellmid Limited

Price: 0.11 AUD

ASX:CDY
Market: ASX
Market Cap: $13.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cellmid Limited to supply rapid diagnostic tests to help in new pandemic

Cellmid Limited (ASX:CDY) CEO Maria Halasz tells Proactive's Andrew Scott they've signed an agreement to supply rapid diagnostic tests (RDT), with products expected to arrive in the country by early April. The test uses a virus-specific detection method that delivers results anywhere between...

on 30/3/20

2 min read